default author photo

Libo Yang

Hebei Yiling Pharmaceutical Research Institute - National Key Laboratory of Collateral Disease Research and Innovative Chinese Medicine

Shijiazhuang

China

SCHOLARLY PAPERS

1

DOWNLOADS

85

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Outcomes and Prognostic Factors in 70 Non-Survivors and 595 Survivors with COVID-19 in Wuhan, China

Number of pages: 24 Posted: 23 Apr 2020
Wuhan Ninth Hospital, Hebei Yiling Pharmaceutical Research Institute - National Key Laboratory of Collateral Disease Research and Innovative Chinese Medicine, Yidu Cloud Technology Inc., Hebei Yiling Pharmaceutical Research Institute - National Key Laboratory of Collateral Disease Research and Innovative Chinese Medicine, Wuhan Ninth Hospital, Yidu Cloud Technology Inc., Hebei Yiling Pharmaceutical Research Institute - National Key Laboratory of Collateral Disease Research and Innovative Chinese Medicine, Wuhan Ninth Hospital, Yidu Cloud Technology Inc., Yidu Cloud Technology Inc., Yidu Cloud Technology Inc., Hebei Yiling Pharmaceutical Research Institute - National Key Laboratory of Collateral Disease Research and Innovative Chinese Medicine and Wuhan Ninth Hospital
Downloads 85 (771,553)

Abstract:

Loading...

2019 Novel Coronavirus; acute respiratory disease, fatality, prognosis